-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Bicara Therapeutics Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2023 to Q3 2025.
- Bicara Therapeutics Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2025 was -$36.3M, a 108% decline year-over-year.
- Bicara Therapeutics Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2025 was -$122M, a 104% decline year-over-year.
- Bicara Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$68M, a 30.8% decline from 2023.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)